Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century

Authors

  • Simone A. Glynn,

    Corresponding author
    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
      Simone A. Glynn, MD, MSc, MPH, Transfusion Medicine and Cellular Therapeutics Branch, Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Bethesda, MD 20892; e-mail: glynnsa@nhlbi.nih.gov.
    Search for more papers by this author
  • Michael P. Busch,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • Roger Y. Dodd,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • Louis M. Katz,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • Susan L. Stramer,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • Harvey G. Klein,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • Graham Simmons,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • Steven H. Kleinman,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • Susan B. Shurin,

    1. From the National Heart, Lung, and Blood Institute and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Blood Systems Research Institute, University of California at San Francisco, San Francisco, California; American Red Cross, Rockville, Maryland; Mississippi Valley Regional Blood Center, Davenport, Iowa; American Red Cross, Gaithesburg, Maryland; and the University of British Columbia, Vancouver, British Columbia, Canada.
    Search for more papers by this author
  • NHLBI Emerging Infectious Disease Task Force convened November 7, 2011


Simone A. Glynn, MD, MSc, MPH, Transfusion Medicine and Cellular Therapeutics Branch, Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Bethesda, MD 20892; e-mail: glynnsa@nhlbi.nih.gov.

Ancillary